Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012
Clinical trial NCT03784625 · COMPLETED
Trial details
- NCT number
- NCT03784625
- Sponsor
- Centre Jean Perrin
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2025-01-17
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.